Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
about
B Cells and Autoantibodies in Multiple SclerosisRole of regulatory b cells in neuroimmunologic disordersFulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathologyAutoantibodies to MOG in a distinct subgroup of adult multiple sclerosisMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeMyelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India.The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.Serological markers associated with neuromyelitis optica spectrum disorders in South India.A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.Atypical Optic Neuritis.The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies.Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome.Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.Pattern Recognition of the Multiple Sclerosis Syndrome.Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?Optic Neuritis in the Older Chinese Population: A 5-Year Follow-Up Study.Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.A case of relapsing-remitting tumour-like inflammation of the central nervous system.Defining distinct features of anti-MOG antibody associated central nervous system demyelination.The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa.Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report.MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment responseOptical coherence tomography in central nervous system demyelinating diseases related optic neuritisBlood Brain Barrier Permeability Could Be a Biomarker to Predict Severity of Neuromyelitis Optica Spectrum Disorders: A Retrospective Analysis
P2860
Q26801386-BD45D824-D850-4731-BDD0-39B6EFDBC373Q28077219-7F86D40C-407A-45A7-AE77-4B1EDB921F31Q28270042-B610A1A7-6F2E-4575-B653-C72265CEB4E0Q29036090-8CD596EE-9ABD-4DAA-8B25-0ADA4F947B32Q30371412-3A2AADF4-8FE8-40EC-A59D-2C7CF442E8D3Q33645795-5A3903B9-F5F1-401E-BF4A-EAF38B1FE572Q33693049-DE863AC6-6C96-446C-8DF9-AB1347B267B6Q36171516-40FD93A0-0DB5-4787-9B15-3DB38967C873Q37374434-EC467D48-5E57-4C09-AD01-0206D56B7778Q37383555-64E144CD-6AB3-4FC0-88F9-DE81131B0694Q37402026-6AAA35C3-5D99-477B-AE40-DB7138801A35Q37484413-68F91D32-E3E0-4DB6-9987-BEB3ADDE4F41Q38538127-C9328FC2-157F-41D4-935E-6EF04C902A77Q38607165-32AD69D4-999A-43E0-BACA-292B95019A42Q38714054-92F6D370-C867-41A7-AEF7-140437BA355AQ38853499-BCE971D0-46B7-4C55-A7A2-06C9656EDB68Q39408205-462EEE5B-EC5B-4461-A0FC-5A666F5AC52BQ40545113-A191CEDC-FB32-4F09-BECD-77AC6681BE51Q40565668-053C05FF-E550-4753-A4EF-682B0382465EQ41106804-AC0F1C42-9548-4C3B-ADAD-A363892F3716Q41927942-22AC07C8-7115-44A6-88F2-1C3DF981DDF1Q42627948-B3A91F0B-30B4-405D-BB66-93060C45B26BQ44875571-0F38C016-98FD-4272-8B18-C798EE4FB30CQ47096340-1C4C7E19-7B33-4A9E-BB50-C12EF2740144Q47999882-0540C46E-CA7D-49CA-AFCC-2E30C701A711Q48154578-C234A7FC-F7E7-4DFB-91A2-EBAFD86B25BFQ51327401-17517F3B-0CEC-4925-A9B2-8D92FE4FCE4FQ52149420-8D0B4C81-E3C3-4AF6-AD3E-22EB05EB00EBQ52603606-6CDBB585-79EB-457E-B132-D12944D60914Q53739884-3FC7A0E8-32E1-47E2-8443-38EBE79B3551Q55054339-FCC7CD52-BC96-4E6B-ADC9-E31B0C065CD8Q55221002-72A6C869-152E-4D07-893D-901A6FD3A75BQ56673306-A5698A54-83A0-4A06-A3AB-BE93694EB94FQ58597236-6E3CDE0D-0B74-422B-8A25-1C57915B7405Q58797276-E1F316D5-DC7F-43A2-B04D-CA9FDC973C60
P2860
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@ast
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en-gb
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@nl
type
label
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@ast
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en-gb
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@nl
prefLabel
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@ast
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en-gb
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@nl
P2093
P2860
P50
P3181
P1476
Anti-MOG antibodies are presen ...... neuromyelitis optica phenotype
@en
P2093
Anne-Katrin Pröbstel
Jean-Baptiste Chanson
Jérôme de Seze
Klaus Dornmair
Nicholas S R Sanderson
Raija L P Lindberg
Tobias Derfuss
P2860
P2888
P3181
P356
10.1186/S12974-015-0256-1
P407
P577
2015-01-01T00:00:00Z
P5875
P6179
1030331690